181 related articles for article (PubMed ID: 32320860)
1. Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.
Birch JL; Coull BJ; Spender LC; Watt C; Willison A; Syed N; Chalmers AJ; Hossain-Ibrahim MK; Inman GJ
Cell Signal; 2020 Aug; 72():109638. PubMed ID: 32320860
[TBL] [Abstract][Full Text] [Related]
2. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Nana AW; Yang PM; Lin HY
Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
Andreou T; Williams J; Brownlie RJ; Salmond RJ; Watson E; Shaw G; Melcher A; Wurdak H; Short SC; Lorger M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707311
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-1 modulates TGFβ signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy.
Kwiatkowski SC; Guerrero PA; Hirota S; Chen Z; Morales JE; Aghi M; McCarty JH
PLoS One; 2017; 12(9):e0185065. PubMed ID: 28938007
[TBL] [Abstract][Full Text] [Related]
5. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
6. Induction of senescence in primary glioblastoma cells by serum and TGFβ.
Kumar R; Gont A; Perkins TJ; Hanson JEL; Lorimer IAJ
Sci Rep; 2017 May; 7(1):2156. PubMed ID: 28526854
[TBL] [Abstract][Full Text] [Related]
7. TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma.
Xie Y; Chen L; Zhou J; Yang C; Xu C; Fan X; Tan Y; Wang Y; Kang C; Fang C
Cancer Biol Med; 2020 Aug; 17(3):664-675. PubMed ID: 32944398
[No Abstract] [Full Text] [Related]
8. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.
Cosset EC; Godet J; Entz-Werlé N; Guérin E; Guenot D; Froelich S; Bonnet D; Pinel S; Plenat F; Chastagner P; Dontenwill M; Martin S
Int J Cancer; 2012 Aug; 131(3):601-11. PubMed ID: 21901744
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.
Wick W; Naumann U; Weller M
Curr Pharm Des; 2006; 12(3):341-9. PubMed ID: 16454748
[TBL] [Abstract][Full Text] [Related]
11. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner.
Zhao K; Cui X; Wang Q; Fang C; Tan Y; Wang Y; Yi K; Yang C; You H; Shang R; Wang J; Kang C
Cell Death Dis; 2019 Nov; 10(12):877. PubMed ID: 31754093
[TBL] [Abstract][Full Text] [Related]
13. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
Ouanouki A; Lamy S; Annabi B
Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition.
Wang Z; Liu Z; Yu G; Nie X; Jia W; Liu RE; Xu R
Neurochem Res; 2018 Mar; 43(3):760-774. PubMed ID: 29423667
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor signaling regulates growth of glioblastoma multiforme in men.
Yu X; Jiang Y; Wei W; Cong P; Ding Y; Xiang L; Wu K
Tumour Biol; 2015 Feb; 36(2):967-72. PubMed ID: 25315188
[TBL] [Abstract][Full Text] [Related]
17. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Bierie B; Moses HL
Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
[TBL] [Abstract][Full Text] [Related]
18. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors.
Roy LO; Poirier MB; Fortin D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484
[TBL] [Abstract][Full Text] [Related]
19. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma precision therapy: From the bench to the clinic.
Zhou Y; Wu W; Bi H; Yang D; Zhang C
Cancer Lett; 2020 Apr; 475():79-91. PubMed ID: 32004571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
